Skip to content

Author

Srijita Chatterjee

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Structural biology of the dengue virus NS2B-NS3 protease as a target for antiviral drug development.

A comprehensive overview of the detailed structural information of the viral protease (NS2B/NS3) enzyme with the mechanistic role of this enzyme, and various inhibitors related to the NS2B/NS3 protease are highlighted.

Rahit Paul, Deeti Jyothi, Maitreyee Mukherjee et al. · 0 citations
Review Sep 2026

Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers

The rapid evolution of KRAS-targeted therapeutic agents represents a shift from allele-specific inhibition towards a strategy that is mutation/context-dependent, thereby creating further clinical translation opportunities and increased patient benefit.

Srijita Chatterjee, S. Arya, Nidhi Sharma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.